Search Results - "Mina, Syeda"

Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease by Mina, Syeda A., Muhsen, Ibrahim N., Hashmi, Shahrukh K.

“…As cellular therapies gradually become the mainstay of treatment for several nonmalignant diseases, there appears to be varied accessibility to these therapies…”
Get full text

Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States by Iftikhar, Mustafa, Junaid, Nadia, Lemus, Marili, Mallick, Zyannah N., Mina, Syeda A., Hannan, Urooba, Canner, Joseph K., Latif, Asad, Shah, Syed Mahmood Ali

“…To determine the national estimates, demographics, and costs of inpatient eye care in the United States (US). Retrospective cross-sectional study. National…”
Get full text

Radial artery access is under‐utilized in women undergoing PCI despite potential benefits: Mayo Clinic PCI Registry by Chester, Rebecca C., Mina, Syeda A., Lewis, Bradley, Zhang, Nan, Butterfield, Richard, Yang, Eric H.

“…Background Women may benefit from radial artery access (RAA) for percutaneous coronary interventions (PCI) due to a higher risk of bleeding compared to men;…”
Get full text

Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness by Blair, Janis E., Gotimukul, Ashwini, Wang, Fangfang, Mina, Syeda A., Bartels, Helen C., Burns, Mark W., Kole, Amy E., Vikram, Holenarasipur R., Gea-Banacloche, Juan C., Seville, M. Teresa, Petty, Skye A. Buckner, Vikram, Avinash, Orenstein, Robert

“…Most patients with coronavirus disease 2019 (COVID-19) have mild to moderate illness not requiring hospitalization. However, no study has detailed the…”
Get full text

Post-Marketing Analysis of Peripheral Neuropathy Burden with New-Generation Proteasome Inhibitors Using the FDA Adverse Event Reporting System by Mina, Syeda A., Muhsen, Ibrahim N., Burns, Ethan A., Sarfraz, Humaira, Pingali, Sai Ravi, Xu, Jiaqiong, Hashmi, Shahrukh K.

“…Proteasome inhibitors (PIs) are an integral component of multiple myeloma therapies. Peripheral neuropathy (PN) is a well-knownconsequence of PIs, most…”
Get full text

Splenic metastasis arising from recurrent nasopharyngeal carcinoma: a rare case report by Abu-Zaid, Ahmed, Qureshi, Sarah, Mina, Syeda, Safwat, Yasmeen, Sulaimanie, Shrouq, Azzam, Ayman, Mohammed, Shamayel, Amin, Tarek

Get full text

Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis by Sonbol, Mohamad Bassam, Riaz, Irbaz Bin, Naqvi, Syed Arsalan Ahmed, Almquist, Daniel R, Mina, Syeda, Almasri, Jehad, Shah, Shiv, Almader-Douglas, Diana, Uson Junior, Pedro Luiz Serrano, Mahipal, Amit, Ma, Wen Wee, Jin, Zhaohui, Mody, Kabir, Starr, Jason, Borad, Mitesh J, Ahn, Daniel H, Murad, M Hassan, Bekaii-Saab, Tanios

“…The treatment landscape for advanced hepatocellular carcinoma (HCC) has recently changed and become relatively confusing. Head-to-head comparisons between most…”
Get more information

Co-occurring alterations across molecular pathways in metastatic colorectal cancer (mCRC) by Liu, Alex John, Walden, Daniel, Mina, Syeda, Langlais, Blake, Drusbosky, Leylah, Yang, Dong, Starr, Jason S., Jones, Jeremy Clifton, Bekaii-Saab, Tanios S., Ahn, Daniel H., Sonbol, Mohamad B.

“…3590 Background: Co-occurring alterations (COAs) in the HER2 and MAPK pathway are rare in mCRC. RAS, HER2 and BRAF alterations have been associated with…”
Get full text

Perceived influential factors toward participation in undergraduate research activities among medical students at Alfaisal University-College of Medicine: A Saudi Arabian perspective by Mina, Syeda, Mostafa, Sowshan, Albarqawi, Haneen Thabit, Alnajjar, Asma, Obeidat, Akef S., Alkattan, Wael, Abu-Zaid, Ahmed

“…Aims: (1) To explore correlations between medical students' participation in undergraduate research (UR) activities and their characteristics, and (2) to…”
Get full text

Post-Marketing Analysis of Peripheral Neuropathy Burden with Newer Generation Proteasome Inhibitors Using the FDA Adverse Event Reporting System (FAERS) Mina et al. Peripheral Neuropathy and Proteasome Inhibitors by Mina, Syeda A., Muhsen, Ibrahim N., Burns, Ethan A., Sarfaraz, Humaira, Pingali, Sai Ravi, Xu, Jiaqiong, Hashmi, Shahrukh K.

Get full text

The influence of curricula and role models on medical students’ professional self-identification: a reminder call by Abu-Zaid, Ahmed, Alkhatib, Lynn, Mina, Syeda

Get full text

The Student-Authored Biomedical Publications at Alfaisal University, Saudi Arabia: a 6-year descriptive analysis by Alnajjar, Asma, Khan, Tehreem A., Mina, Syeda, Alkattan, Khaled, Abu-Zaid, Ahmed

“…There are limited numbers of studies which comprehensively explored the research publications authored by medical students. To descriptively analyze the…”
Get full text